Elanco Animal Health Incorporated
NYSEELAN reported Q1 2026 results on May 6 that landed well ahead of consensus, and the stock's response has put short sellers firmly on the back foot. Adjusted EPS came in at $0.40 against a $0.35 estimate. Sales hit $1.371 billion, an $83 million beat and an 15% jump versus the year-ago quarter. Management then raised the full-year revenue guide to $5.010–$5.085 billion (from…
Snapshot as of 6 May 2026
ELAN reported Q1 2026 results on May 6 that landed well ahead of consensus, and the stock's response has put short sellers firmly on the back foot. Adjusted EPS came in at $0.40 against a $0.35 estimate. Sales hit…
Elanco Animal Health reports Q1 2026 results on May 6 with the Street broadly constructive — but the stock has spent the past month drifting lower, testing how much of that optimism is already in the price. The analyst…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELAN — free to start on ORTEX.
Sign up for free →Open ELAN on ORTEX